Dianthus Therapeutics (DNTH) Depreciation & Amortization (CF) (2017 - 2025)
Dianthus Therapeutics' quarterly Depreciation & Amortization (CF) came in at $27000.0 in Q3 2025, up 8.0% year-on-year from $25000.0 in Q3 2024, and down 10.0% quarter-over-quarter from $30000.0 in Q2 2025.
Dianthus Therapeutics has reported Depreciation & Amortization (CF) for 9 years, with the latest figure at $27000.0 in Q3 2025.
- For the quarter ending Q3 2025, Depreciation & Amortization (CF) rose 8.0% year-over-year to $27000.0; the trailing twelve-month figure through Dec 2025 stood at $84000.0 (down 12.5% YoY), and the FY2024 full-year result was $96000.0, up 43.28% from the prior year.
- Depreciation & Amortization (CF) for Q3 2025 stood at $27000.0, down from $30000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $532000.0 in Q3 2021, with the low at $19000.0 in Q3 2023.
- Average Depreciation & Amortization (CF) over 5 years is $253611.1, with a median of $225500.0 recorded in 2023.
- Year-over-year, Depreciation & Amortization (CF) slumped 95.97% in 2023 and surged 31.58% in 2024.
- Tracing DNTH's Depreciation & Amortization (CF) over 5 years: stood at $515000.0 in 2021, then fell by 9.51% to $466000.0 in 2022, then plunged by 95.71% to $20000.0 in 2023, then gained by 30.0% to $26000.0 in 2024, then grew by 3.85% to $27000.0 in 2025.
- The last three Depreciation & Amortization (CF) figures came in at $27000.0 (Q3 2025), $30000.0 (Q2 2025), and $27000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 55.90 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 123.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 13.55 Mn |
| 10 | Dianthus Therapeutics | 4.02 Bn | 3.62 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 27,000.00 |
| Sep 30, 2025 | 27,000.00 |
| Jun 30, 2025 | 30,000.00 |
| Jun 30, 2025 | 30,000.00 |
| Mar 31, 2025 | 27,000.00 |
| Mar 31, 2025 | 27,000.00 |
| Dec 31, 2024 | 26,000.00 |
| Dec 31, 2024 | 26,000.00 |
| Sep 30, 2024 | 25,000.00 |
| Sep 30, 2024 | 25,000.00 |
| Jun 30, 2024 | 23,000.00 |
| Jun 30, 2024 | 23,000.00 |
| Mar 31, 2024 | 22,000.00 |
| Mar 31, 2024 | 22,000.00 |
| Dec 31, 2023 | 20,000.00 |
| Dec 31, 2023 | 20,000.00 |
| Sep 30, 2023 | 19,000.00 |
| Sep 30, 2023 | 19,000.00 |
| Mar 31, 2023 | 421,000.00 |
| Mar 31, 2023 | 421,000.00 |
| Dec 31, 2022 | 466,000.00 |
| Dec 31, 2022 | 466,000.00 |
| Sep 30, 2022 | 471,000.00 |
| Sep 30, 2022 | 471,000.00 |
| Jun 30, 2022 | 477,000.00 |
| Jun 30, 2022 | 477,000.00 |
| Mar 31, 2022 | 511,000.00 |
| Mar 31, 2022 | 511,000.00 |
| Dec 31, 2021 | 515,000.00 |
| Dec 31, 2021 | 515,000.00 |
| Sep 30, 2021 | 532,000.00 |
| Sep 30, 2021 | 532,000.00 |
| Jun 30, 2021 | 479,000.00 |
| Jun 30, 2021 | 479,000.00 |
| Mar 31, 2021 | 474,000.00 |
| Mar 31, 2021 | 474,000.00 |
| Dec 31, 2020 | 495,000.00 |
| Dec 31, 2020 | 495,000.00 |
| Sep 30, 2020 | 495,000.00 |
| Sep 30, 2020 | 495,000.00 |
| Jun 30, 2020 | 495,000.00 |
| Jun 30, 2020 | 495,000.00 |
| Mar 31, 2020 | 493,000.00 |
| Mar 31, 2020 | 493,000.00 |
| Dec 31, 2019 | 485,000.00 |
| Dec 31, 2019 | 485,000.00 |
| Sep 30, 2019 | 483,000.00 |
| Sep 30, 2019 | 483,000.00 |
| Jun 30, 2019 | 452,000.00 |
| Jun 30, 2019 | 452,000.00 |
| Mar 31, 2019 | 423,000.00 |
| Mar 31, 2019 | 423,000.00 |
| Dec 31, 2018 | 359,000.00 |
| Dec 31, 2018 | 359,000.00 |
| Sep 30, 2018 | 209,000.00 |
| Sep 30, 2018 | 209,000.00 |
| Jun 30, 2018 | 160,000.00 |
| Jun 30, 2018 | 160,000.00 |
| Mar 31, 2018 | 147,000.00 |
| Mar 31, 2018 | 147,000.00 |
| Dec 31, 2017 | 129,000.00 |
| Dec 31, 2017 | 129,000.00 |
| Sep 30, 2017 | 118,000.00 |
| Sep 30, 2017 | 118,000.00 |